Intervention not reported
Case cross‐over ‐ Jeryl Lynn or Rubini · children 9 months to 15 years old
The intervention showed no clear difference in case cross‐over ‐ Jeryl Lynn or Rubini (low certainty).
1 finding from 1 review
OR 0.6 [0.18, 1.99]
1 study · 1 participants
Low
Intervention not reported
Self‐controlled case series ‐ any strain · children 9 months to 15 years old
The intervention may leads to higher self‐controlled case series ‐ any strain (low certainty).
1 finding from 1 review
Intervention not reported
Self‐controlled case series ‐ Urabe · children 9 months to 15 years old
The intervention may leads to higher self‐controlled case series ‐ Urabe (low certainty).
1 finding from 1 review
Intervention not reported
Self controlled case series ‐ Leningrad‐Zagreb · children 9 months to 15 years old
The intervention showed no clear difference in self controlled case series ‐ Leningrad‐Zagreb (low certainty).
1 finding from 1 review
Intervention not reported
Cohort studies household contacts ‐ 3 doses · children 9 months to 15 years old
The intervention may leads to lower cohort studies household contacts ‐ 3 doses (low certainty).
1 finding from 1 review
Intervention not reported
Person‐time cohort ‐ Jeryl Lynn · children 9 months to 15 years old
The intervention showed no clear difference in person‐time cohort ‐ Jeryl Lynn (low certainty).
1 finding from 1 review
Intervention not reported
Case‐only ecological method ‐ Urabe · children 9 months to 15 years old
The intervention may leads to higher case‐only ecological method ‐ Urabe (low certainty).
1 finding from 1 review
Intervention not reported
Case‐only ecological method ‐ Leningrad‐Zagreb · children 9 months to 15 years old
The intervention may leads to higher case‐only ecological method ‐ Leningrad‐Zagreb (low certainty).
1 finding from 1 review
Intervention not reported
Cohort studies ‐ within 1 week after MMR vaccination · children 9 months to 15 years old
The intervention probably leads to higher cohort studies ‐ within 1 week after MMR vaccination (moderate certainty).
1 finding from 1 review
Intervention not reported
Cohort studies ‐ between 1 and 2 weeks after MMR vaccination · children 9 months to 15 years old
The intervention probably leads to higher cohort studies ‐ between 1 and 2 weeks after MMR vaccination (moderate certainty).
1 finding from 1 review
Intervention not reported
Cohort studies ‐ > 2 weeks after MMR vaccination · children 9 months to 15 years old
The intervention showed no clear difference in cohort studies ‐ > 2 weeks after MMR vaccination (low certainty).
1 finding from 1 review
Intervention not reported
Self‐controlled case series/person‐time ‐ between 1 and 2 weeks after MMR vaccination · children 9 months to 15 years old
The intervention may leads to higher self‐controlled case series/person‐time ‐ between 1 and 2 weeks… (low certainty).
1 finding from 1 review
Intervention not reported
Self‐controlled case series/person‐time ‐ > 2 weeks after MMR vaccination · children 9 months to 15 years old
The intervention showed no clear difference in self‐controlled case series/person‐time ‐ > 2 weeks after MMR… (low certainty).
1 finding from 1 review
Intervention not reported
Self‐controlled case series/person‐time ‐ between 1 and 2 weeks after vaccination; MMRV · children 9 months to 15 years old
The intervention may leads to higher self‐controlled case series/person‐time ‐ between 1 and 2 weeks… (low certainty).
1 finding from 1 review
Intervention not reported
Self‐controlled case series/person‐time ‐ between 1 and 2 weeks after MMR+V vaccination · children 9 months to 15 years old
The intervention may leads to higher self‐controlled case series/person‐time ‐ between 1 and 2 weeks… (low certainty).
1 finding from 1 review
Intervention not reported
Cohort studies postexposure prophylaxis · children 9 months to 15 years old
The intervention may leads to lower cohort studies postexposure prophylaxis (low certainty).
1 finding from 1 review
Intervention not reported
MMRV vs MMR+V ‐ by brand ‐ from 0 to 42 days after vaccination (Priorix‐Tetra) · children 9 months to 15 years old
The intervention showed no clear difference in MMRV vs MMR+V ‐ by brand ‐ from 0 to 42 days after vaccination… (low certainty).
1 finding from 1 review
Intervention not reported
MMRV vs MMR+V ‐ by brand ‐ from 7 to 10 days after vaccination (Priorix‐Tetra) · children 9 months to 15 years old
The intervention showed no clear difference in MMRV vs MMR+V ‐ by brand ‐ from 7 to 10 days after vaccination… (low certainty).
1 finding from 1 review
Intervention not reported
MMRV vs MMR+V ‐ by brand ‐ from 0 to 42 days after vaccination (ProQuad) · children 9 months to 15 years old
The intervention may leads to higher MMRV vs MMR+V ‐ by brand ‐ from 0 to 42 days after vaccination… (low certainty).
1 finding from 1 review
Intervention not reported
MMRV vs MMR+V ‐ by brand ‐ from 7 to 10 days after vaccination (ProQuad) · children 9 months to 15 years old
The intervention may leads to higher MMRV vs MMR+V ‐ by brand ‐ from 7 to 10 days after vaccination… (low certainty).
1 finding from 1 review